ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cailes, J.
Right arrow Articles by du Bois, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cailes, J.
Right arrow Articles by du Bois, R.
Eur Respir J 1996; 9: 992-999
Copyright © ERS Journals Ltd 1996

Original Articles

Neutrophil activation in fibrosing alveolitis: a comparison of lone cryptogenic fibrosing alveolitis and systemic sclerosis

JB Cailes, C O'Connor, P Pantelidis, AM Southcott, MX Fitzgerald, CM Black, and RM du Bois

Fibrosing alveolitis complicating systemic sclerosis (FASSc) carries a better prognosis than lone cryptogenic fibrosing alveolitis (CFA). We wanted to determine whether this improved prognosis is associated with differential neutrophil migration and activation in the lower respiratory tract. We therefore compared bronchoalveolar lavage (BAL) neutrophil numbers and levels of neutrophil-derived enzymes in FASSc, CFA and normal individuals. Bronchoalveolar lavage was performed on 45 subjects (FASSc n = 20; CFA n = 15; normals n = 10); cell counts and levels of neutrophil-derived enzymes, myeloperoxidase, elastase (total elastase and elastase/alpha 1 antitrypsin complexes), collagenase and lactoferrin were measured. Lung function testing was performed in subjects with fibrosing alveolitis. Significant differences in the levels of collagenase, myeloperoxidase and elastase/ alpha 1-antitrypsin complexes were present in the BAL fluid from the three groups. Patients with CFA had significantly higher neutrophil percentages and levels of collagenase and myeloperoxidase than those with FASSc. Disease extent, as judged by lung volumes and gas transfer, was comparable in the CFA and FASSc groups. Forced vital capacity (% predicted) was significantly lower in patients with evidence of increased neutrophil enzyme release than those without. We conclude that: 1) increased neutrophil migration to the lung is accompanied by release both of primary and secondary granule enzymes in cryptogenic fibrosing alveolitis; and 2) the lower amounts of neutrophil products in fibrosing alveolitis complicating systemic sclerosis may account for the improved prognosis, even when disease is as extensive as in cryptogenic fibrosing alveolitis.


This article has been cited by other articles:


Home page
 The Journal of RheumatologyHome page
T. HARA, F. OGAWA, K. YANABA, Y. IWATA, E. MUROI, K. KOMURA, M. TAKENAKA, K. SHIMIZU, M. HASEGAWA, M. FUJIMOTO, et al.
Elevated Serum Concentrations of Polymorphonuclear Neutrophilic Leukocyte Elastase in Systemic Sclerosis: Association with Pulmonary Fibrosis
J Rheumatol, January 1, 2009; 36(1): 99 - 105.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
F. Chua and G. J. Laurent
Neutrophil elastase: mediator of extracellular matrix destruction and accumulation.
Proceedings of the ATS, July 1, 2006; 3(5): 424 - 427.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
P. Bonniaud, P. J. Margetts, M. Kolb, J. A. Schroeder, A. M. Kapoun, D. Damm, A. Murphy, S. Chakravarty, S. Dugar, L. Higgins, et al.
Progressive Transforming Growth Factor {beta}1-induced Lung Fibrosis Is Blocked by an Orally Active ALK5 Kinase Inhibitor
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 889 - 898.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Cisneros-Lira, M. Gaxiola, C. Ramos, M. Selman, and A. Pardo
Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs
Am J Physiol Lung Cell Mol Physiol, October 1, 2003; 285(4): L949 - L956.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Pardo, V. Ruiz, J. L. Arreola, R. Ramirez, J. Cisneros-Lira, M. Gaxiola, R. Barrios, S. V. Kala, M. W. Lieberman, and M. Selman
Bleomycin-induced Pulmonary Fibrosis Is Attenuated in {gamma}-Glutamyl Transpeptidase-Deficient Mice
Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 925 - 932.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
S.-I. HAGIWARA, Y. ISHII, and S. KITAMURA
Aerosolized Administration of N-Acetylcysteine Attenuates Lung Fibrosis Induced by Bleomycin in Mice
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 225 - 231.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. PARDO, R. BARRIOS, M. GAXIOLA, L. SEGURA-VALDEZ, G. CARRILLO, A. ESTRADA, M. MEJÍA, and M. SELMAN
Increase of Lung Neutrophils in Hypersensitivity Pneumonitis Is Associated with Lung Fibrosis
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1698 - 1704.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. SCHNABEL, E. CSERNOK, J. BRAUN, and W. L. GROSS
Activation of Neutrophils, Eosinophils, and Lymphocytes in the Lower Respiratory Tract in Wegener's Granulomatosis
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 399 - 405.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A. Schnabel, E. Csernok, J. Braun, and W. L Gross
Inflammatory cells and cellular activation in the lower respiratory tract in Churg-Strauss syndrome
Thorax, September 1, 1999; 54(9): 771 - 778.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the European Respiratory Society.